Healthy Volunteers Clinical Trial
Official title:
The Effect of Gravity on the Muscular Control of Landing From a Jump
In this project, investigators propose to study the jump in different reduced gravity fields
obtained during parabolic flights profiles but also during increased gravity fields obtained
during turns of the airplane or during the pull-up phase of the parabola. By means of a
pneumatic device, an additional pull-down force will be added to the vertical force caused
by the gravity field. By combining different levels of gravity to different levels of the
added pull-down force it will be possible to dissociate the respective contribution of the
otolithic and proprioceptive systems to the anticipatory landing response. To the
investigators' knowledge, only one study has modified the gravity field during a jump.
However, these authors did not add a pull-down force and only analyzed the vertical ground
reaction force.
A better knowledge of the sensory-motor control of the landing phase of a jump will also
increase the investigators' understanding of the physiopathology of joint instability.
Indeed, similarities could be found between the evolution of the motor response due to the
absence gravity during long-duration space flights and the pathological process of chronic
ankle and knee instability. The knowledge generated by this study will thus provide
invaluable information in the context of human performance and rehabilitation.
Investigations description ----------------------------------
During the experiments, subjects will jump in different gravity fields while submitted to an
additional pull-down force equal to 0-100% of their body weight on Earth. During the takeoff
and landing phases of the jumps, the ground reaction force will be recorded by a
force-platform, the movements of the limb segments will be recorded by means of a high-speed
camera and the electrical activity (EMG) of the main lower limb muscles will be recorded by
means of surface electrodes.
Force platform and Subject Loading System We have developed a device that combines a force
platform on which the subject jumps and a Subject Loading System (SLS) that pulls the
subject downwards.
The force platform is a 60 cm x 40 cm aluminum plate equipped with four force-transducers
that measure the three components of the force exerted by the subject's feet on the ground.
The SLS consists in two pneumatic pistons, which are attached to a harness on one end and to
the aluminum plate on the other. The SLS can be set to generate a force equal to 20-100% of
the subject's body weight on Earth.
A security handrail (not shown on the picture) is attached to the aluminum plate, around the
force-platform in case of unbalance of the subject.
EMG EMG will be recorded with a MyoSystem 1400L using surface electrodes. The skin will be
shaved (if necessary) and the electrodes will be attached with double sided tape and
plaster. The electrodes will be placed at the level of the lateral gastrocnemius, medial
gastrocnemius, tibialis anterior and peroneus longus, and on the thigh at the level of the
vastus lateralis, vastus medialis and lateral hamstrings and medial hamstrings. There will
be 2 electrodes per muscle (fixed one against the other) and one reference electrode placed
at the level of the C7 vertebra.
Manufacturer: Noraxon. Conformity certificate: CE 344
Video Movements of the subject will be recorded by means of a high-speed digital camera
(Basler). In order to facilitate video analysis, 7 reflective markers (hemisphere with a 12
mm diameter) will delimit body segments: 3 will be glued on one shoe, 3 will be fixed on the
skin (with the same method used for EMG electrodes) at the level of the ankle, knee, hip of
one limb and the last one will be fixed on the neck.
Experimental protocol
Before flight subjects will be familiarized with the setup and the protocol. For each flight
day, one subject will be studied. The procedure will be the following on all 3 days.
The experiment day starts at 7.30 a.m. with the test subject equipped with EMG electrodes
and video markers. After take-off and after work is permitted, the subject goes to the
experimental area where it is equipped with the SLS harness. Before each parabola, the
subject stands beside the platform to adjust the zero level of the sensor (about 3 second).
Then the subject steps on the platform to record his weight (about 3 second).
During the hypergravity initial part in of the parabola, the subject is standing with is two
feet on each side of the platform. The traction system is loose (5 kg traction). During the
injection, the traction system starts to progressively pull downwards on the subject. The
traction force is tuned between 20% and 100% of body weight on Earth. The traction force is
constant during each parabola. During the 20 second of weightlessness or partial gravity,
the subject jumps several times. At the end of the parabola, the subject puts his feet at
the side of the platform and the traction system stops to pull downwards before the pull out
phase.
This experiment will also be performed during periods of increased gravity obtained during
turns of the airplane. Three turns per flight should be performed at 3 levels of gravity:
1.2, 1.4 g and 1.6 g.
During each parabola or turn, one experimenter is taking care of the control of the traction
system and of the collection of the data, a second one takes care of the image acquisition,
and a third one takes care of the modification of the configuration of the harness between
the parabolas and of the safety of the subject in case of unbalance during the parabolas or
during the turn.
;
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00995891 -
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
|
||
Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 |